MAR-GABAPENTIN
MAR-GABAPENTIN
Dormant
DIN Number
02391481
Drug Class
Human
Market Date
Jan 8, 2014
Company
HC
marcan pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02391481
AIG Number0125929003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF01 GABAPENTIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
GABAPENTINActive
Strength: 300 MG
Monograph: GABAPENTIN